PPARG and metabolic dysfunction-associated steatotic liver disease: For example, hepatic PPARγ expression is elevated in animals that develop fatty livers [18-20], and increased PPARγ2 expression is correlated with increased liver fat in human subjects with non-alcoholic fatty liver disease (NAFLD) [21].